The Role of Serum Matrix Metalloproteinase-9 as a Predictor of Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage

Akpinar A, Ucler N, Erdogan U, Baydin SS, Gungor A, Tugcu B (2016) Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm. Springerplus 22:1153. https://doi.org/10.1186/s40064-016-2837-6

Article  CAS  Google Scholar 

Chan V, Lindsay P, McQuiggan J, Zagorski B, Hill MD, O’Kelly C (2019) Declining admission and mortality rates for subarachnoid hemorrhage in Canada between 2004 and 2015. Stroke 50(1):181–184. https://doi.org/10.1161/STROKEAHA.118.022332. Epub 2018 Nov 21. PMID: 30580710

Article  PubMed  Google Scholar 

Chang JJ, Triano M, Corbin MJ, Desale S, Liu AH, Felbaum DR et al (2020) Transcranial Doppler velocity and associations with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. J Neurol Sci 15(415):116934. https://doi.org/10.1016/j.jns.2020.116934

Article  Google Scholar 

Chou SHY, Feske SK, Simmons SL, Konisberg GJ, Orzell SC (2011) Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage. Transl Stroke Res 2:600–607. https://doi.org/10.1007/s12975-011-0117-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dang B, Shen H, Li H, Zhu M, Guo C, He W (2016) Matrix metalloproteinase 9 may be involved in contraction of vascular smooth muscle cells in an in vitro rat model of subarachnoid hemorrhage. Mol Med Rep 14:4279–4284. https://doi.org/10.3892/mmr.2016.5736

Article  CAS  PubMed  Google Scholar 

Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V (2009) Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 8:355–369. https://doi.org/10.1016/S1474-4422(09)70025-0

Article  PubMed  Google Scholar 

Fischer M, Dietmann A, Beer R, Broessner G, Helbok R, Pfausler B et al (2013) Differential regulation of matrix-metalloproteinases and their tissue inhibitors in patients with aneurysmal subarachnoid hemorrhage. PLoS ONE 8:e59952. https://doi.org/10.1371/journal.pone.0059952

Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

Kiiski H, Långsjö J, Tenhunen J, Ala-Peijari M, Huhtala H, Hämäläinend M et al (2018) S100B, NSE and MMP-9 fail to predict neurologic outcome while elevated S100B associates with milder initial clinical presentation after aneurysmal subarachnoid hemorrhage. J Neurol Sci 15(390):129–134. https://doi.org/10.1016/j.jns.2018.04.030

Article  CAS  Google Scholar 

Mc Girt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitx DT (2002) Serum von Willebrand factor, matrix metalloproteinase 9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 51:1128–1134. https://doi.org/10.1097/00006123-200211000-00005

Article  PubMed  Google Scholar 

Mehta V, Russin J, Spirtos A, He S, Adamczyk P, Amar AP, Mack WJ (2013) Matrix metalloproteinases in cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res Int 2013:943761. https://doi.org/10.1155/2013/943761. Epub 2013 Apr 3. PMID: 23691315; PMCID: PMC3649803

Article  PubMed  PubMed Central  Google Scholar 

Rosenberg GA (1995) Matrix metalloproteinases in brain injury. J Neurotrauma 12:833–842. https://doi.org/10.1089/neu.1995.12.833

Article  CAS  PubMed  Google Scholar 

Rowland MJ, Hsdjipavlou G, Kelly M, Westbrook J, Pattinson KTS (2012) Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. Br J Anaesth 109:315–329. https://doi.org/10.1093/bja/aes264

Article  CAS  PubMed  Google Scholar 

Samagh N, Bhagat H, Jangra K (2019) Monitoring cerebral vasospasm: how much can we rely on transcranial Doppler. J Anaesthesiol Clin Pharmacol 35:12–18. https://doi.org/10.4103/joacp.JOACP_192_17

Article  PubMed  PubMed Central  Google Scholar 

Sharma T, Datta KK, Kumar M, Dey G, Khan AA, Mangalaparthi KK et al (2020) Intracranial aneurysm biomarker candidates identified by a proteome-wide study. OMICS 24:483–492. https://doi.org/10.1089/omi.2020.0057

Article  CAS  PubMed  Google Scholar 

Triglia T, Mezzapesa A, Martin JC, Verdier M, Lagier D (2016) Early matrix metalloproteinase-9 concentration in the first 48h after aneurysmal subarachnoid haemorrhage predicts delayed cerebral ischaemia. Eur J Anaesthesiol 33:662–669. https://doi.org/10.1097/EJA.0000000000000494

Article  CAS  PubMed  Google Scholar 

Vergouwen MDI, Vermeulen M, van Gijn J, Rinkel GJE, Wijdicks EF et al (2010) Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 41:2391–2395. https://doi.org/10.1161/STROKEAHA.110.589275

Article  PubMed  Google Scholar 

Wang Z, Fang Q, Dang BQ, Shen XM, Shu Z, Zuo G, He WC, Chen G (2012) Potential contribution of matrix metalloproteinase-9 (mmp-9) to cerebral vasospasm after experimental subarachnoid hemorrhage in rats. Ann Clin Lab Sci 42(1):14–20 PMID: 22371905

PubMed  Google Scholar 

留言 (0)

沒有登入
gif